SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is surging following a strong quarterly beat and raise, with the community actively discussing a shift in market perception as the company rebrands itself as a core player in AI infrastructure. Investors are debating the sustainability of this momentum, weighing concerns about capital intensity and valuation against excitement for a potential long-term CPU renaissance and foundry strategy execution.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is surging to record highs, driven by investor enthusiasm following Intel's earnings beat and broad sector rotation into semiconductor and AI-focused infrastructure plays. While the community is split between bullish sentiment over long-term AI megatrends and concerns regarding potential overvaluation, many traders are closely watching for continued momentum into the upcoming earnings cycle.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

The Direxion Daily Semiconductor Bear 3X Shares (SOXS) is trending as investors struggle with a relentless, multi-week rally in semiconductor stocks that has left the fund significantly depressed and near historic lows. The community remains heavily divided, with many debating whether this semiconductor sector strength represents an unsustainable bubble nearing a "blow-off top" or a continuation of an AI-driven supercycle that makes betting against the trend a dangerous "falling knife" scenario.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is seeing massive volatility driven by extreme AI chip demand, a semiconductor supply "super cycle," and intense community debate over whether the surge represents a historic bubble or a persistent, momentum-driven melt-up. While bulls are riding the parabolic trend with high-leverage positions and dismissing pullbacks, skeptics are actively shorting the symbol, citing comparisons to past market manias and unsustainable valuation levels.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending as investors debate its massive market cap against high-growth semiconductor peers like AMD and Intel, with the community closely tracking its strategic partnerships and the broader impact of AI infrastructure demand. Discussion remains polarized, with many retail traders frustrated by the stock's recent sideways movement compared to the wider chip sector, while others argue that its dominant ecosystem position makes it a long-term anchor for the AI trade.

Skillz, Inc. operates a mobile gaming platform that connects players in competition. It helps developers build franchises by enabling social competition in their games. Skillz hosts casual esports tournaments for mobile players worldwide. The company was founded by Andrew C Paradise and Casey Chafkin in 2012 and is headquartered in Las Vegas, NV.

Skillz Inc - Ordinary Shares - Class A

Skillz Inc

Skillz Inc. is experiencing extreme volatility and massive trading volume following a jury verdict that awarded the company over $1 billion in damages and disgorgement against a rival for fraudulent bot usage. The community is heavily focused on the potential for a major short squeeze due to the company's tight float and the significant legal catalyst, with traders debating whether to hold for triple-digit gains or exit into the intense retail-driven momentum.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is experiencing intense volatility driven by speculative trading around Middle East ceasefire headlines and ongoing semiconductor sector concentration. Investors are actively debating whether the current rally is a sustainable AI-led bull cycle or a precarious bubble vulnerable to geopolitical shocks and unsustainable valuation levels.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending as investors react to volatility driven by the company's expansion into GLP-1 treatments and broader market concerns regarding potential competition from Amazon. The community remains divided, with bullish participants pointing to strong subscriber growth and platform potential as a catalyst for a short squeeze, while bears highlight valuation concerns and the impact of the competitive landscape on margins.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying as investors react to confirmed production orders linked to Marvell and broader expectations that its optical interposer platform is becoming critical to AI data center infrastructure. The community is actively debating the stock's transition from speculative R&D to commercial execution, with strong enthusiasm regarding hyperscale partnerships and the potential for the company to become an industry standard in optical connectivity.

Lakewood-Amedex Biotherapeutics Inc.

Lakewood-Amedex Biotherapeutics is experiencing extreme volatility and massive trading volume following the lifting of its IPO quotation resumption halt. Investors are closely monitoring the price action as the stock establishes its initial market footing, with active community debate focused on technical support levels and the potential for sharp intraday swings typical of newly listed biotech equities.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Repligen (NASDAQ:RGEN) Reaches New 1-Year Low - Should You Sell?

Repligen (NASDAQ:RGEN) Reaches New 1-Year Low - Here's What Happened...

Repligen (NASDAQ:RGEN) Stock Price Down 10.3%  - Time to Sell?

Repligen (NASDAQ:RGEN) Trading Down 10.3% - Should You Sell...

M&T Bank Corp Purchases New Holdings in Repligen Corporation $RGEN

M&T Bank Corp purchased a new stake in shares of Repligen Corporation (NASDAQ:RGEN - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange...

Repligen (NASDAQ:RGEN) Earns Buy Rating from Analysts at Roth Mkm

Roth Mkm initiated coverage on shares of Repligen in a research note on Friday. They issued a "buy" rating and a $160.00 price target for the company...

Short Interest in Repligen Corporation (NASDAQ:RGEN) Rises By 28.0%

Repligen Corporation (NASDAQ:RGEN - Get Free Report) was the recipient of a significant increase in short interest in March. As of March 31st, there was short interest totaling 5,556,333 shares, an...

Massachusetts Financial Services Co. MA Makes New $199.18 Million Investment in Repligen Corporation $RGEN

Massachusetts Financial Services Co. MA acquired a new position in Repligen Corporation (NASDAQ:RGEN - Free Report) in the fourth quarter, according to the company in its most recent filing with the...

Repligen Corporation (NASDAQ:RGEN) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Repligen Corporation (NASDAQ:RGEN - Get Free Report) have received an average recommendation of "Moderate Buy" from the fourteen brokerages that are covering the company, Marketbeat.com...

Are Options Traders Betting on a Big Move in Repligen Stock?

Investors need to pay close attention to RGEN stock based on the movements in the options market lately.

Riverbridge Partners LLC Sells 30,070 Shares of Repligen Corporation $RGEN

Riverbridge Partners LLC reduced its position in Repligen Corporation (NASDAQ:RGEN - Free Report) by 8.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 313,365 shares of the biotechn...

Repligen (RGEN) Down 13.5% Since Last Earnings Report: Can It Rebound?

Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

RGEN
Repligen Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest RGEN News

RGENRepligen Corp.